文献速递眼底病与葡萄膜炎

高多重病原体面板检测用于感染性葡萄膜炎诊断的临床评估

Clinical Assessment of a Highly Multiplexed Panel Assay for the Diagnosis of Infectious Uveitis.
PubMed 文献 · Am J Ophthalmol · 2025-12-31

该研究评估了一种可同时检测46种眼部病原体及2种耐药/毒力标志物的高多重PCR面板(OcuPan)在感染性葡萄膜炎中的诊断性能。纳入109例患者(78例感染性葡萄膜炎,31例对照),OcuPan的临床敏感度为50.9%,特异度为100%,与PCR总体一致率为93.5%。未稀释玻璃体阳性率最高(72.4%),且定量指标与实时PCR循环阈值显著相关。

要点

  • OcuPan检测感染性葡萄膜炎的敏感度为50.9%,特异度为100%。
  • 未稀释玻璃体阳性率最高(72.4%),房水最低(36.7%)。
  • 与PCR总体一致率93.5%,疱疹病毒和梅毒螺旋体PPA为100%。

核心结论

  • OcuPan检测是一种快速、全面、定量且准确的一体化高多重病原体检测系统,可用于感染性葡萄膜炎的诊断。

研究设计与样本

  • 研究为新型诊断技术的实验室评估,纳入2个中心的109例患者,包括78例感染性葡萄膜炎病例和31例对照。
  • 检测患者眼内样本108份和对照样本43份,采用PCR和OcuPan检测(可检测46种眼部病原体及2种耐药/毒力标志物)。

主要发现

  • OcuPan检测的临床敏感度为50.9%(95% CI,41.3-60.5),特异度为100%(95% CI,89.7%-100%)。
  • 敏感度因样本基质而异:未稀释玻璃体阳性率72.4%(95% CI,55.1-89.7),稀释玻璃体53.3%(95% CI,34.4-72.3),房水36.7%(95% CI,22.7-50.7)。
  • OcuPan与PCR总体一致率为93.5%(kappa=0.870±0.047;P<.001),所有靶标的阳性百分比一致率(PPA)和阴性百分比一致率(NPA)均>92%。
  • 疱疹病毒和梅毒螺旋体的PPA为100%,NPA为96.6%至100%;刚地弓形虫的PPA为75%,NPA为100%。
  • OcuPan定量指标与实时PCR循环阈值显著相关(Spearman ρ=-0.7506,P<.0001)。

关键数值与推荐

  • OcuPan检测可检测46种眼部病原体及2种耐药/毒力标志物,周转时间12小时。
  • 临床敏感度50.9%(95% CI,41.3-60.5),特异度100%(95% CI,89.7%-100%)。
  • 未稀释玻璃体阳性率72.4%(95% CI,55.1-89.7),稀释玻璃体53.3%(95% CI,34.4-72.3),房水36.7%(95% CI,22.7-50.7)。
  • 与PCR总体一致率93.5%(kappa=0.870±0.047;P<.001),所有靶标PPA和NPA均>92%。
  • 疱疹病毒和梅毒螺旋体PPA为100%,NPA为96.6%至100%;刚地弓形虫PPA为75%,NPA为100%。

临床怎么用

  • OcuPan检测可作为感染性葡萄膜炎的快速一体化病原体检测工具,尤其适用于未稀释玻璃体样本。
  • 该检测与PCR高度一致,并提供定量信息,有助于临床诊断和病情评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Current diagnostic workup for infectious uveitis relies on the use of various immunoassays and polymerase chain reaction (PCR) tests on ocular fluids that are time consuming and not comprehensive, requiring large sample volumes to probe for all causes. To streamline the diagnostic process, improve turnaround time, and target inclusivity, we developed a highly multiplexed pan-ocular-pathogen panel (OcuPan) that can be used for broad-range pathogen detection in only 1 assay, with PCR-level sensitivity and in a timely fashion (12 hours). Here, we assessed the clinical usefulness and performance of this innovative assay as a novel tool for rapid and accurate laboratory diagnosis of infectious uveitis. DESIGN: Laboratory evaluation of a novel diagnostic test and technology PARTICIPANTS AND CONTROLS: A total of 109 patients from 2 centers were included, including 78 infectious uveitis cases and 31 controls. METHODS: Intraocular samples (n = 108 from patients and 43 from controls) were processed by PCR and the OcuPan diagnostic assay that detects 46 ocular pathogens plus 2 resistance/virulence markers. MAIN OUTCOME MEASURES: Clinical sensitivity and specificity, quantification capabilities, and agreement between PCR and the OcuPan assay. RESULTS: The clinical sensitivity and specificity of the OcuPan assay were 50.9% (95% CI, 41.3-60.5) and 100% (95% CI 89.7%-100%), respectively. Sensitivity varied according to the sample matrix tested, with undiluted vitreous having the highest positivity rates (72.4%, 95% CI 55.1-89.7), followed by dilute vitreous (53.3%, 95% CI 34.4-72.3) and aqueous (36.7%, 95% CI 22.7-50.7). There was excellent overall agreement (93.5%) between the OcuPan assay and PCR (kappa of 0.870 ± 0.047; P < .001) with positive (PPA) and negative (NPA) percentage agreements >92% for all targets. PPA was 100% for herpesviruses and Treponema pallidum, whereas the NPA values ranged from 96.6% to 100% for these pathogens. For Toxoplasma gondii, the PPA was 75% and NPA 100%. We also found significant correlation (Spearman ρ = -0.7506, P < .0001) between the quantitative metric for the OcuPan assay and the real-time PCR cycle threshold values. CONCLUSIONS: The OcuPan assay offers an all-in-one highly multiplexed detection system for rapid, comprehensive, quantitative, and accurate diagnosis of infectious uveitis.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Bispo PJM, Belanger NL, Liu R, et al. Clinical Assessment of a Highly Multiplexed Panel Assay for the Diagnosis of Infectious Uveitis. Am J Ophthalmol. 2025. PMID: 41482070. doi:10.1016/j.ajo.2025.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。